TY - JOUR
T1 - Chemical and biological characterization of low-molecular-weight human skeletal growth factor
AU - Mohan, Subburaman
AU - Linkhart, Thomas
AU - Jennings, John
AU - Baylink, David
N1 - Funding Information:
We are grateful for the expert technical assistance of Tracey Moreno, Christopher Hans and Joe Rung-Aroon. We thank Penny Nasabal and Linda Carrillo for their help with the manuscript and Medical Media for illustrations. This investigation was supported by funds from NIH grant AM31062, Veteran's Administration and Departments of Medicine and Pediatrics, Loma Linda University.
PY - 1986/11/19
Y1 - 1986/11/19
N2 - Skeletal growth factor (SGF) activity was extracted from human bone matrix by demineralization and purified under dissociative conditions using hydroxyapatite, HPLC gel-filtration and HPLC reverse-phase chromatography. Human SGF thus purified was characterized chemically and biologically. Purified human SGF stimulated chick embryo bone cell proliferation at picomolar concentrations (half maximum at 2-3 ng/ml) and had little or no activity on other cell types tested (mouse 3T3 and normal rat kidney fibroblasts, embryonic chick intestinal and human placental cells). Human SGF did not displace 125I-labeled epidermal growth factor finding to normal rat kidney cells and did not stimulate normal rat kidney cell colony formation in soft agar. Human SGF activity was sensitive to trypsin, chymotrypsin, papain, dithiothreitol and performic acid but was resistant to heat (upto 70°C), pH (3-10), cyanogen bromide, alkaline phosphatase and neuraminidase and did not bind jack bean concanavalin A or kidney bean lectin. From our chemical and biological studies it appears that human SGF is different from other known polypeptide growth factors: epidermal growth factor, fibroblast growth factor, insulin, insulin-like growth factor-I, platelet-derived growth factor and transforming growth factor.
AB - Skeletal growth factor (SGF) activity was extracted from human bone matrix by demineralization and purified under dissociative conditions using hydroxyapatite, HPLC gel-filtration and HPLC reverse-phase chromatography. Human SGF thus purified was characterized chemically and biologically. Purified human SGF stimulated chick embryo bone cell proliferation at picomolar concentrations (half maximum at 2-3 ng/ml) and had little or no activity on other cell types tested (mouse 3T3 and normal rat kidney fibroblasts, embryonic chick intestinal and human placental cells). Human SGF did not displace 125I-labeled epidermal growth factor finding to normal rat kidney cells and did not stimulate normal rat kidney cell colony formation in soft agar. Human SGF activity was sensitive to trypsin, chymotrypsin, papain, dithiothreitol and performic acid but was resistant to heat (upto 70°C), pH (3-10), cyanogen bromide, alkaline phosphatase and neuraminidase and did not bind jack bean concanavalin A or kidney bean lectin. From our chemical and biological studies it appears that human SGF is different from other known polypeptide growth factors: epidermal growth factor, fibroblast growth factor, insulin, insulin-like growth factor-I, platelet-derived growth factor and transforming growth factor.
KW - Bone matrix protein
KW - Cell proliferation
KW - Growth factor
UR - http://www.scopus.com/inward/record.url?scp=0023003743&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023003743&partnerID=8YFLogxK
U2 - 10.1016/0304-4165(86)90169-8
DO - 10.1016/0304-4165(86)90169-8
M3 - Article
C2 - 3490278
SN - 0304-4165
VL - 884
SP - 243
EP - 250
JO - Biochimica et Biophysica Acta - General Subjects
JF - Biochimica et Biophysica Acta - General Subjects
IS - 2
ER -